Foyston, Gordon, & Payne’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-38,204
| Closed | -$2.21M | – | 62 |
|
|
2018
Q2 | $2.21M | Sell |
38,204
-37,256
| -49% | -$2.1M | 0.41% | 45 |
|
|
2018
Q1 | $3.92M | Sell |
75,460
-3,061
| -4% | -$165K | 0.76% | 33 |
|
|
2017
Q4 | $4.22M | Sell |
78,521
-3,675
| -4% | -$204K | 0.8% | 35 |
|
|
2017
Q3 | $5.02M | Sell |
82,196
-909
| -1% | -$55.1K | 0.87% | 30 |
|
|
2017
Q2 | $5.08M | Sell |
83,105
-654
| -0.8% | -$39.8K | 1.1% | 28 |
|
|
2017
Q1 | $5.08M | Buy |
83,759
+1,380
| +2% | +$83.7K | 1.1% | 29 |
|
|
2016
Q4 | $4.63M | Sell |
82,379
-38,913
| -32% | -$2.28M | 1.1% | 30 |
|
|
2016
Q3 | $7.22M | Sell |
121,292
-34,989
| -22% | -$2.05M | 1.39% | 26 |
|
|
2016
Q2 | $8.59M | Sell |
156,281
-853
| -0.5% | -$45.4K | 1.57% | 22 |
|
|
2016
Q1 | $7.93M | Buy |
157,134
+12,283
| +8% | +$602K | 1.48% | 27 |
|
|
2015
Q4 | $7.3M | Sell |
144,851
-8,175
| -5% | -$412K | 1.38% | 27 |
|
|
2015
Q3 | $7.21M | Buy |
153,026
+8,258
| +6% | +$439K | 1.34% | 33 |
|
|
2015
Q2 | $7.86M | Sell |
144,768
-7,666
| -5% | -$430K | 1.18% | 33 |
|
|
2015
Q1 | $8.36M | Sell |
152,434
-16,411
| -10% | -$929K | 1.23% | 30 |
|
|
2014
Q4 | $9.15M | Buy |
168,845
+356
| +0.2% | +$19.8K | 1.31% | 30 |
|
|
2014
Q3 | $9.53M | Sell |
168,489
-15,269
| -8% | -$857K | 1.37% | 29 |
|
|
2014
Q2 | $10.1M | Sell |
183,758
-50,409
| -22% | -$2.75M | 1.29% | 31 |
|
|
2014
Q1 | $12.7M | Sell |
234,167
-56,956
| -20% | -$2.95M | 1.56% | 28 |
|
|
2013
Q4 | $13.9M | Buy |
291,123
+29,239
| +11% | +$1.34M | 1.73% | 23 |
|
|
2013
Q3 | $11.9M | Sell |
261,884
-48,176
| -16% | -$2.2M | 1.55% | 26 |
|
|
2013
Q2 | $13.7M | Buy |
+310,060
| New | +$13.8M | 2.05% | 19 |
|
Other funds holding MRK
